Outcomes of pediatric patients with oncologic disease or following hematopoietic stem cell transplant supported on extracorporeal membrane oxygenation: The PEDECOR experience.

Pediatric Blood & Cancer
Diana A SteppanPediatric ECMO (PediECMO) subgroup of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network and the Extr

Abstract

Outcomes for patients with oncologic disease and/or after hematopoietic stem cell transplant (HSCT) requiring intensive care unit admission have improved, but indications for and outcomes after extracorporeal membrane oxygenation (ECMO) support in this population are poorly characterized. We analyzed data from consecutive patients < 18 years with oncologic disease and/or after HSCT reported to a pediatric ECMO registry by nine pediatric centers in the United States between 2011 and 2018. We identified 18 ECMO patients with oncologic disease and/or HSCT, and 415 ECMO controls matched with a propensity score algorithm based on age, gender, race, severity of illness at admission, and reason for ECMO. The primary indication for ECMO was respiratory failure in 66.7% in the oncologic disease and/or HSCT group, and in 70.7% in the matched ECMO control group. Eleven of 18 patients survived to hospital discharge (61.1%), similar to the matched control group (60.8%), P = 0.979. Children with oncologic disease and/or HSCT had lower mean platelet counts during ECMO and received higher volumes of platelets compared with the control group, mean 14.6 mL/kg/day (standard deviations [SD], 9.8) versus mean 9.3 mL/kg/day (SD, 10.4), P = 0.001. Of...Continue Reading

References

Apr 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J P KrischerS E Lipshultz
Nov 5, 1997·Journal of Pediatric Hematology/oncology·T LehrnbecherS J Chanock
May 29, 1998·Bone Marrow Transplantation·A M LeaheyK E Sullivan
Feb 24, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·P E Kintzel
May 27, 2004·Pediatric Hematology and Oncology·Sascha MeyerNorbert Graf
May 1, 2008·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Robert F TamburroElaine M Sillos
Oct 14, 2009·British Journal of Haematology·Bernhard MeisterNikolaus Neu
Aug 31, 2010·Paediatric Drugs·Maria Giuseppina CefaloRiccardo Riccardi
Dec 1, 2010·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Jacqueline OngGraeme Maclaren
May 3, 2011·American Journal of Respiratory and Critical Care Medicine·Angela Panoskaltsis-MortariUNKNOWN American Thoracic Society Committee on Idiopathic Pneumonia Syndrome
Jul 14, 2012·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Ranjit S ChimaSonata Jodele
Aug 21, 2012·Journal of Intensive Care Medicine·François AspesberroJoan S Roberts
May 13, 2015·Pediatric Transplantation·Madeleine S DidsburySean E Kennedy
Jul 15, 2015·The Korean Journal of Internal Medicine·Hye Seon KangJong Wook Lee
Dec 18, 2015·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Corrine R BalitPeter N Cox
Feb 26, 2016·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Courtney M RowanUNKNOWN Investigators of the Pediatric Acute Lung Injury and Sepsis Network
Nov 23, 2016·Perfusion·Chinmay Patvardhan, Kamen Valchanov
Jan 6, 2017·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Mar 23, 2017·American Journal of Respiratory and Critical Care Medicine·Heidi J DaltonUNKNOWN Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Resear
Apr 15, 2017·Critical Care Medicine·Philipp WohlfarthUNKNOWN Caring for Critically Ill Immunocompromised Patients Multinational Network (NINE-I)
May 27, 2017·Respiratory Care·Lama ElbahlawanDennis C Stokes
May 31, 2017·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Ryan P BarbaroUNKNOWN ELSO member centers
Aug 2, 2017·British Journal of Clinical Pharmacology·Antonio RuggieroRiccardo Riccardi
Sep 25, 2017·Pediatric Clinics of North America·Julia A Heneghan, Murray M Pollack
Sep 21, 2018·Critical Care : the Official Journal of the Critical Care Forum·Graeme MacLaren
May 3, 2019·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Ryan D ColemanLara S Shekerdemian
Sep 1, 2014·Journal of Pediatric Intensive Care·Orly R Klein, Kenneth R Cooke
Aug 14, 2019·Critical Reviews in Oncology/hematology·Roelie M Wösten-van AsperenUNKNOWN POKER (PICU Oncology Kids in Europe Research group) research consortium

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.